Kratos (KTOS) Insider Sells 4,000 Shares Under 10b5-1 Plan
Rhea-AI Filing Summary
Kratos Defense & Security Solutions insider Stacey G. Rock, President of the KTT Division, reported sales of company common stock executed on 09/02/2025 under a 10b5-1 trading plan adopted May 22, 2024. The filing shows two sale entries: 1,717 shares sold at a weighted average price of $63.619 and 2,283 shares sold at a weighted average price of $64.617, for total reported sales of 4,000 shares.
Post-transaction beneficial ownership is reported as 40,411 shares on one line and 38,128 shares on the other, with additional holdings noted including 1,723 shares from the Employee Stock Purchase Plan and approximately 6,699 shares held in the company 401(k) plan. The reporting person certified the Form 4 via attorney-in-fact on 09/04/2025.
Positive
- Transactions were disclosed under a 10b5-1 trading plan, indicating preplanned sales and compliance with insider trading policies.
- Full transparency in the filing including weighted average prices and offer to provide per-price breakdowns on request.
Negative
- Insider sold a total of 4,000 shares, which reduces the reporting person’s direct holdings (reported post-sale holdings: 40,411 and 38,128 on respective lines).
Insights
TL;DR: Insider sold 4,000 shares under a pre-existing 10b5-1 plan; transactions appear routine and disclosed properly.
The Form 4 discloses two discrete sale blocks totaling 4,000 shares executed on 09/02/2025 at weighted average prices of $63.619 and $64.617. The seller used a 10b5-1 plan adopted May 22, 2024, which typically signals preplanned disposition rather than opportunistic trading. Post-sale beneficial ownership is reported in the high tens of thousands, and the filing includes holdings through the ESPP and 401(k). For investors, this is a transparent, rule-compliant insider sale, without additional company-level financial data in the filing to assess broader impact.
TL;DR: Filing follows Section 16 disclosure norms; use of 10b5-1 plan and attorney-in-fact signature are documented.
The report clearly checks the 10b5-1 box and includes explanatory footnotes about weighted average pricing and plan adoption date, which aligns with best-practice disclosure. The signature executed by an attorney-in-fact on 09/04/2025 is noted. There is no indication in the filing of amendments or other governance events. The disclosure is complete for the transactions reported and provides to the issuer and SEC a willingness to disclose per-footnote price breakdowns on request.